Mitigation of diabetes type II-induced nephropathy by ellagic acid nanoformulations: Amended glycemic control, oxidative stress, inflammation, and induced apoptosis

Mitigation of diabetes type II-induced nephropathy by ellagic acid nanoformulations: Amended glycemic control, oxidative stress, inflammation, and induced apoptosis

Diabetic nephropathy is a significant medical condition that arises from elevated blood sugar levels associated with both type I and type II diabetes. Recent research has indicated that ellagic acid (EA), either alone or in combination with other medications, can provide anti-diabetic benefits. This...

Full description

Bibliographic Details
Main Authors: Steve Harakeh, Saber Hassan Saber, Nagla El-Shitany, Soad S. Ali, Turki Alamri, Mohammed W. Al-Rabia, Addisu Demeke Teklemariam, Kawther A. Zaher, Zeina W. Sharawi, Shafiul Haque, Manal Naseeb, Eram A. Albajri, Shaker Mousa
Format: Article
Language:English
Published: Elsevier 2023-10-01
Series:Journal of King Saud University: Science
Subjects:
Diabetes type II
Kidney
Ellagic acid
Nanoformulations
Lipid peroxidation
C reactive protein
Online Access:http://www.sciencedirect.com/science/article/pii/S1018364723002367

Internet

http://www.sciencedirect.com/science/article/pii/S1018364723002367

Similar Items